Q-Bank Breakdown: Thiazides — Why Every Answer Choice Matters | StepGenie Blog

You’re on a question block, and the stem screams “hypertension.” You’re thinking thiazide, you click thiazide… and then you realize half the answer choices were also “BP meds,” and you’re not 100% sure why they’re wrong in this specific patient. That’s the real skill USMLE tests: not just knowing what thiazides do, but knowing why every distractor doesn’t fit the vignette.

Tag: Cardiovascular > Cardiac Pharmacology

The Clinical Vignette

A 56-year-old man comes to clinic for follow-up. He has essential hypertension and started a new medication 6 weeks ago. His blood pressure improved from 156/94 mm Hg to 132/82 mm Hg. He now reports occasional muscle cramps and “feels tired.” He has no chest pain or dyspnea.

Labs:

Na $^+$ : 138 mEq/L
K $^+$ : 3.1 mEq/L
Cl $^-$ : 100 mEq/L
HCO $_3^-$ : 30 mEq/L
Glucose: 132 mg/dL (fasting 110 baseline)
Uric acid: 9.2 mg/dL (baseline 6.8)

Which medication was most likely started?

A. Hydrochlorothiazide
B. Spironolactone
C. Lisinopril
D. Furosemide
E. Amlodipine

Step 1: Identify the Pattern (Before You Look at the Choices)

The key triad in this stem:

Hypokalemia (K $^+$ 3.1)
Metabolic alkalosis (HCO $_3^-$ 30)
Hyperglycemia + hyperuricemia

That constellation is classic for a thiazide diuretic (and can also be seen with loop diuretics for the first two, but not as “classically bundled” with hyperglycemia/hyperuricemia in outpatient HTN vignettes).

Correct Answer: A. Hydrochlorothiazide

Why thiazides fit perfectly

Mechanism (high-yield):

Thiazides inhibit the NaCl cotransporter (NCC) in the distal convoluted tubule (DCT)

What this causes:

Mild diuresis → lowers plasma volume → lowers BP
Increased Na $^+$ delivery to collecting tubule → increased K $^+$ and H $^+$ secretion → hypokalemic metabolic alkalosis
Hyperglycemia (decreased insulin release and/or worsened insulin sensitivity; hypokalemia can impair insulin secretion)
Hyperuricemia (competition at proximal tubule transport → decreased urate secretion)
Increased Ca $^{2+}$ reabsorption in DCT → lower urinary Ca $^{2+}$ (good for calcium stone prevention)

USMLE buzzwords for thiazides

“HyperGLUC” adverse effects: HyperGlycemia, HyperLipidemia, HyperUricemia, HyperCalcemia
Sulfa allergy risk (most thiazides are sulfonamides)
Can cause hyponatremia (especially older adults)

Why Each Distractor Is Wrong (and What It Would Look Like)

B. Spironolactone

What it is: aldosterone antagonist (K $^+$ -sparing diuretic), acts in collecting duct

Why it’s wrong here:

Would cause hyperkalemia, not hypokalemia
Would cause metabolic acidosis (type 4 RTA physiology) due to decreased H $^+$ secretion, not metabolic alkalosis

When it is the answer:

Resistant HTN, primary hyperaldosteronism, heart failure with reduced EF (HFrEF)
Stem clues: gynecomastia, decreased libido, menstrual irregularities

High-yield pearl:
Spironolactone helps in hyperaldosteronism because it blocks aldosterone’s effects → decreases Na $^+$ reabsorption and prevents K $^+$ wasting.

C. Lisinopril

What it is: ACE inhibitor → decreases angiotensin II and aldosterone; increases bradykinin

Why it’s wrong here:

ACE inhibitors tend to cause hyperkalemia, not hypokalemia (less aldosterone → less K $^+$ secretion)
They do not cause metabolic alkalosis in the classic diuretic way
The stem gives diuretic-type metabolic findings (hypoK + alkalosis + uric acid up)

When it is the answer:

HTN with diabetes (renal protection), CKD with albuminuria, HFrEF, post-MI
Stem clues: cough, angioedema, increased creatinine after initiation (especially renal artery stenosis)

High-yield contraindications:

Pregnancy
Bilateral renal artery stenosis (or stenosis of solitary kidney)

D. Furosemide

What it is: loop diuretic, inhibits Na-K-2Cl (NKCC2) in thick ascending limb

Why it’s wrong here (subtle but important):

Loop diuretics can absolutely cause hypokalemic metabolic alkalosis—so why not furosemide?
Because the vignette is outpatient essential HTN with mild side effects and metabolic profile that screams thiazide (hyperglycemia + hyperuricemia are board-classic thiazide associations in HTN management)
Loop diuretics are more typical when you need powerful diuresis (edema states), not first-line uncomplicated HTN

When it is the answer:

Pulmonary edema/acute decompensated HF, cirrhosis/ascites, nephrotic syndrome
Hypercalcemia (loops increase Ca $^{2+}$ excretion)

High-yield adverse effects:
“OHH DAANG”

Ototoxicity
Hypokalemia
Hypocalcemia
Dehydration
Allergy (sulfa)
Alkalosis (metabolic)
Nephritis (interstitial)
Gout

E. Amlodipine

What it is: dihydropyridine calcium channel blocker (CCB) → vasodilation of arterioles

Why it’s wrong here:

Dihydropyridine CCBs do not cause hypokalemia or metabolic alkalosis
They don’t raise uric acid as a classic effect
Their hallmark side effects are vascular, not electrolyte/metabolic

When it is the answer:

HTN (especially in Black patients as first-line), stable angina, Raynaud phenomenon
Stem clues: peripheral edema, flushing, headache, reflex tachycardia, gingival hyperplasia (less common)

High-yield distinction:

Dihydropyridines (amlodipine, nifedipine): more vasodilation
Non-dihydropyridines (verapamil, diltiazem): more cardiac effects (↓ AV conduction)

Rapid Comparison Table (How to Win These Fast)

Drug/Class	Site/Mechanism	K $^+$ effect	Acid-base	Signature adverse clues
Thiazide (HCTZ)	DCT, blocks NaCl cotransporter	↓ K $^+$	Metabolic alkalosis	HyperGLUC, hyponatremia, ↑ Ca $^{2+}$
Loop (furosemide)	TAL, blocks NKCC2	↓ K $^+$	Metabolic alkalosis	Ototoxicity, hypocalcemia, gout
ACEi (lisinopril)	↓ Ang II, ↓ aldosterone, ↑ bradykinin	↑ K $^+$	—	Cough, angioedema, teratogen
K $^+$ -sparing (spironolactone)	Collecting duct, anti-aldosterone	↑ K $^+$	Metabolic acidosis	Gynecomastia, type 4 RTA vibe
DHP CCB (amlodipine)	Arteriolar vasodilation	no major change	—	Edema, flushing, headache

High-Yield Takeaways (Test-Day Ready)

Thiazides: think outpatient HTN + hypokalemic metabolic alkalosis + hyperuricemia and sometimes hyperglycemia.
Thiazides increase Ca $^{2+}$ reabsorption → helpful in recurrent calcium stones.
Loops waste Ca $^{2+}$ , thiazides save Ca $^{2+}$ .
Electrolyte/acid-base clues often matter more than the chief complaint.

One More Layer: The “Why” Behind Hypokalemic Metabolic Alkalosis

Diuretics that increase Na $^+$ delivery to the collecting duct set up a predictable downstream effect:

More Na $^+$ reabsorbed via ENaC
Lumen becomes more negative
More K $^+$ secretion (ROMK) and H $^+$ secretion (α-intercalated cells)
Result: hypokalemia + metabolic alkalosis

That’s why thiazides and loops can share this acid-base pattern—then you use the rest of the stem (edema? Ca $^{2+}$ ? uric acid? outpatient HTN?) to pick the correct one.